Chevy Chase Trust’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,000,000
Closed -$969K 691
2020
Q4
$969K Sell
2,000,000
-619,143
-24% -$313K ﹤0.01% 569
2020
Q3
$1.43M Hold
2,619,143
0.01% 552
2020
Q2
$1.81M Hold
2,619,143
0.01% 538
2020
Q1
$2.21M Hold
2,619,143
0.01% 518
2019
Q4
$4.29M Buy
2,619,143
+182,295
+7% +$274K 0.02% 524
2019
Q3
$2.71M Buy
2,436,848
+436,848
+22% +$505K 0.01% 533
2019
Q2
$2.48M Hold
2,000,000
0.01% 540
2019
Q1
$2.6M Hold
2,000,000
0.01% 538
2018
Q4
$2.36M Buy
+2,000,000
New +$2.97M 0.01% 540

Other funds holding GEN

Chevy Chase Trust's GEN Position: Q1 2021 in Review

Chevy Chase Trust sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 2,000,000 shares — an estimated $969K sold.

Chevy Chase Trust first reported a position in GEN in Q4 2018 and held it in 9 quarters. The position peaked at $4.29M in Q4 2019. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • Chevy Chase Trust reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • Chevy Chase Trust sold 2,000,000 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $969K.
  • Chevy Chase Trust first reported a position in Genesis Healthcare, Inc. in Q4 2018 and held it in 9 quarters.
  • Chevy Chase Trust's Genesis Healthcare, Inc. position peaked at $4.29M in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Chevy Chase Trust's 13F filing for Q1 2021, filed 22 Apr 2021.